Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Jesse F. Abelson,1,2*Kenneth Y. Kwan,3,4*Brian J. O'Roak,2*Danielle Y. Baek,1,2Althea A. Stillman,2Thomas M. Morgan,2Carol A. Mathews,8David L. Pauls,9Mladen-Roko Rain,3Murat Gunel,5Nicole R. Davis,1,2A. Gulhan Ercan-Sencicek,1,2Danielle H. Guez,2John A. Spertus,10James F. Leckman,1Leon S. Dure, IV,11Roger Kurlan,12Harvey S. Singer,13Donald L. Gilbert,14Anita Farhi,7Angeliki Louvi,5Richard P. Lifton,2,6,7Nenad estan,3,4Matthew W. State1,2,4,6
Tourette's syndrome (TS) is a genetically influenced developmentalneuropsychiatric disorder characterized by chronic vocal andmotor tics. We studied Slit and Trk-like 1 (SLITRK1) as a candidategene on chromosome 13q31.1 because of its proximity to a denovo chromosomal inversion in a child with TS. Among 174 unrelatedprobands, we identified a frameshift mutation and two independentoccurrences of the identical variant in the binding site formicroRNA hsa-miR-189. These variants were absent from 3600 controlchromosomes. SLITRK1 mRNA and hsa-miR-189 showed an overlappingexpression pattern in brain regions previously implicated inTS. Wild-type SLITRK1, but not the frameshift mutant, enhanceddendritic growth in primary neuronal cultures. Collectively,these findings support the association of rare SLITRK1 sequencevariants with TS.
1 Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA. 2 Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA. 3 Department of Neurobiology, Yale University School of Medicine, New Haven, CT 06520, USA. 4 Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT 06520, USA. 5 Department of Neurosurgery, Yale University School of Medicine, New Haven, CT 06520, USA. 6 Center for Human Genetics and Genomics, Yale University School of Medicine, New Haven, CT 06520, USA. 7 Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA. 8 Department of Psychiatry, University of CaliforniaSan Diego, San Diego, CA 92093, USA. 9 Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. 10 Department of Medicine, University of MissouriKansas City, Kansas City, MO 64111, USA. 11 Division of Pediatric Neurology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA. 12 Department of Neurology, University of Rochester School of Medicine, Rochester, NY 14642, USA. 13 Departments of Neurology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. 14 Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: matthew.state{at}yale.edu
Principal components analysis of a large cohort with Tourette syndrome.
M. M. Robertson, R. R. Althoff, A. Hafez, and D. L. Pauls (2008)
The British Journal of Psychiatry
193, 31-36
|Abstract »|Full Text »|PDF »
Mapping translocation breakpoints by next-generation sequencing.
W. Chen, V. Kalscheuer, A. Tzschach, C. Menzel, R. Ullmann, M. H. Schulz, F. Erdogan, N. Li, Z. Kijas, G. Arkesteijn, et al. (2008)
Genome Res.
18, 1143-1149
|Abstract »|Full Text »|PDF »
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.
K. Chen, F. Song, G. A. Calin, Q. Wei, X. Hao, and W. Zhang (2008)
Carcinogenesis
29, 1306-1311
|Abstract »|Full Text »|PDF »
Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.
N. J. Beveridge, P. A. Tooney, A. P. Carroll, E. Gardiner, N. Bowden, R. J. Scott, N. Tran, I. Dedova, and M. J. Cairns (2008)
Hum. Mol. Genet.
17, 1156-1168
|Abstract »|Full Text »|PDF »
LACK OF ASSOCIATION BETWEEN SLITRK1var321 AND TOURETTE SYNDROME IN A LARGE FAMILY-BASED SAMPLE.
J. M. Scharf, P. Moorjani, J. Fagerness, J. V. Platko, C. Illmann, B. Galloway, E. Jenike, S. E. Stewart, D. L. Pauls, and The Tourette Syndrome International Consortium for (2008)
Neurology
70, 1495-1496
|Full Text »|PDF »
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31.
C. Beetz, R. Schule, T. Deconinck, K.-N. Tran-Viet, H. Zhu, B. P.H. Kremer, S. G.M. Frints, W. A.G. van Zelst-Stams, P. Byrne, S. Otto, et al. (2008)
Brain
131, 1078-1086
|Abstract »|Full Text »|PDF »
Sequence Variation of MicroRNAs and Their Binding Sites in Arabidopsis.
I. M. Ehrenreich and M. D. Purugganan (2008)
Plant Physiology
146, 1974-1982
|Abstract »|Full Text »|PDF »
The SALM Family of Adhesion-like Molecules Forms Heteromeric and Homomeric Complexes.
G. K. Seabold, P. Y. Wang, K. Chang, C.-Y. Wang, Y.-X. Wang, R. S. Petralia, and R. J. Wenthold (2008)
J. Biol. Chem.
283, 8395-8405
|Abstract »|Full Text »|PDF »
Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
J. Elmen, M. Lindow, A. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, M. Hedtjarn, J. B. Hansen, H. F. Hansen, E. M. Straarup, et al. (2008)
Nucleic Acids Res.
36, 1153-1162
|Abstract »|Full Text »|PDF »
MicroRNA expression in the adult mouse central nervous system.
M. Bak, A. Silahtaroglu, M. Moller, M. Christensen, M. F. Rath, B. Skryabin, N. Tommerup, and S. Kauppinen (2008)
RNA
14, 432-444
|Abstract »|Full Text »|PDF »
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4.
Q. Wang, Z. Huang, H. Xue, C. Jin, X.-L. Ju, J.-D. J. Han, and Y.-G. Chen (2008)
Blood
111, 588-595
|Abstract »|Full Text »|PDF »
Neural correlates of tic severity and cognitive control in children with Tourette syndrome.
C. L. Baym, B. A. Corbett, S. B. Wright, and S. A. Bunge (2008)
Brain
131, 165-179
|Abstract »|Full Text »|PDF »
Noncoding RNAs in the Brain.
J. S. Satterlee, S. Barbee, P. Jin, A. Krichevsky, S. Salama, G. Schratt, and D.-Y. Wu (2007)
J. Neurosci.
27, 11856-11859
|Abstract »|Full Text »|PDF »
Prediction and Verification of miRNA Expression in Human and Rat Retinas.
A. Arora, G. J. McKay, and D. A. C. Simpson (2007)
Invest. Ophthalmol. Vis. Sci.
48, 3962-3967
|Abstract »|Full Text »|PDF »
Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines.
H. Wu, J. Xu, Z. P. Pang, W. Ge, K. J. Kim, B. Blanchi, C. Chen, T. C. Sudhof, and Y. E. Sun (2007)
PNAS
104, 13821-13826
|Abstract »|Full Text »|PDF »
The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding.
M. M. Martin, J. A. Buckenberger, J. Jiang, G. E. Malana, G. J. Nuovo, M. Chotani, D. S. Feldman, T. D. Schmittgen, and T. S. Elton (2007)
J. Biol. Chem.
282, 24262-24269
|Abstract »|Full Text »|PDF »
Noncoding RNAs and RNA Editing in Brain Development, Functional Diversification, and Neurological Disease.
The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-{alpha} (ER{alpha}) and Represses ER{alpha} Messenger RNA and Protein Expression in Breast Cancer Cell Lines.
B. D. Adams, H. Furneaux, and B. A. White (2007)
Mol. Endocrinol.
21, 1132-1147
|Abstract »|Full Text »|PDF »
miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
S. R. Chamberlain, L. Menzies, B. J. Sahakian, and N. A. Fineberg (2007)
Am J Psychiatry
164, 568-574
|Full Text »|PDF »
Tourette's Syndrome and the Law..
J. Jankovic, C. Kwak, and R. Frankoff (2006)
J Neuropsychiatry Clin Neurosci
18, 86-95
|Abstract »|Full Text »|PDF »
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses.
D. Keen-Kim, C. A. Mathews, V. I. Reus, T. L. Lowe, L. D. Herrera, C. L. Budman, V. Gross-Tsur, A. E. Pulver, R. D. Bruun, G. Erenberg, et al. (2006)
Hum. Mol. Genet.
15, 3324-3328
|Abstract »|Full Text »|PDF »
The contactin 4 gene locus at 3p26 is a candidate gene of SCA16..
S. Miura, H. Shibata, H. Furuya, Y. Ohyagi, M. Osoegawa, Y. Miyoshi, H. Matsunaga, A. Shibata, N. Matsumoto, A. Iwaki, et al. (2006)
Neurology
67, 1236-1241
|Abstract »|Full Text »|PDF »